Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder

NCT: NCT06518785 · RECRUITING

NCT IDNCT06518785
StatusRECRUITING
Start Date2025-01-07
Completion2030-09
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

This study aims to examine the effects of Low-Intensity Focused Ultrasound (LIFU) on brain activity in patients with alcohol use disorder.

Frequently Asked Questions

What is Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder?

Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder is a clinical trial registered under NCT06518785. Current status: RECRUITING.

What is the status of NCT06518785?

The current status of NCT06518785 (Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder) is: RECRUITING.

When did Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder start?

Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder started on 2025-01-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑